Generic User Fees Have Four-Month Negotiating Window As Differences Narrow
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA calculates it that needs to reach an agreement with industry by June in order to have a proposal ready for Congress by early 2012.
You may also be interested in...
GDUFA Stakeholder Deadline Extended; Are Talks Delayed?
FDA says stakeholders who want to participate in monthly updates during formal generic drug user fee talks have until late April 2016 to give notice, prompting questions about the negotiation schedule.
ANDA User Fees: Negotiators Close To Agreement, But Backlog Is Sticking Point
The generics industry does not appear satisfied with an FDA proposal to treat all applications equally under a new generic drug user fee program, preferring instead to create another, separate user fee that would clear the ANDA application backlog faster.
ANDA User Fees: Negotiators Close To Agreement, But Backlog Is Sticking Point
The generics industry does not appear satisfied with an FDA proposal to treat all applications equally under a new generic drug user fee program, preferring instead to create another, separate user fee that would clear the ANDA application backlog faster.